Kazumi Fujikawa, Seed Planning Inc
Kazumi Fujikawa, Title, Seed Planning Inc
Kazumi is well known in the “insight professional circle” for her distinguished experience that includes global, regional and local roles for various multinational corporation: Takeda, Pfizer, IMS, Sanofi-Aventis and has covered a range of responsibilities in her career that includes Product Commercialization Strategy, Market Research and Analytics to Logistics.
She holds BA of English Literature, Notre Dame Seishin University, Japan and holds MBA, Marketing from Leicester University, UK. She is certified, leadership and organizational development from New York University and is certified, MBTI instructor.
She is the Executive Member of Pharma Delegates after serving as a chairperson.
Masako Futagami, Celgene
Masako Futagami, Business Unit Director, Celgene
Masaaki Hattori, Merck
Masaaki Hattori, Commercial Excellence Head, Merck
Carlos Hernandez, Abbott Laboratories
Carlos Hernandez, Head of Market Insights, Abbott Laboratories
Carlos Hernandez is Head of Market Insights for the Global Marketing Organization at Abbott covering Singapore, China and Vietnam. Carlos has 15+ years of experience in consumer and market insights having worked with some of the FMCG leading names from both agency and industry sectors: Nielsen, Kantar, Sainsbury’s and Reckitt Benckiser. Carlos is originally from Portugal but lived most of his life in the UK. He and his family relocated to Singapore 2 ½ years ago.
Haruhiko Hirate, Takeda
Haruhiko Hirate, Corporate Officer, Head of Corporate Affairs and Communication, Takeda
Haruhiko Hirate became Takeda’s Corporate Communications and Public Affairs Officer in October 2014. He previously served as President of North Asia in 2011, and has held Corporate Officer and Senior Vice President positions at Takeda since 2010.
Prior to joining Takeda, Mr. Hirate held the position of Representative Senior Managing Director at GlaxoSmithKline in Japan and, before that, Representative Director and President of Banyu Pharmaceuticals, the Japanese subsidiary of Merck & Co. He joined Banyu Pharmaceuticals in 2004 from his role as Senior Vice President at Merck & Co, based in the U.S. He had previously held the position of Representative Director and President at Roche Diagnostics based in Japan and before that, Asia Pacific Regional President of Draeger.
Mr. Hirate began his career with Nissei Sangyo, a subsidiary of Hitachi, in 1980. During his career at Hitachi group companies, he lived for about five years in Germany, mainly working with former Boehringer Manheim, and a series of overseas projects in the U.S. and Asia between 1980 and 1996.
Well respected in the Japanese pharmaceutical industry, Mr. Hirate served as Director at the Federation of Pharmaceutical Manufacturers Associations of Japan (FPMAJ), and Chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) Japan. In 2012, he became a member of the Japan Association of Corporate Executives. In 2014, he became Chairman of the International Affairs Committee at the Japan Pharmaceutical Manufacturers Association (JPMA).
He graduated from Keio University in Japan with a B.A. degree in economics in 1980.
Masahiro Kajita, Eisai
Masahiro Kajita, Associate Director, Eisai
Ryota Kano, Pfizer
Ryota Kano, Center of Excellence Integrated Marketing Lead, Pfizer
Ryota Kano has been worked for Pfizer more than 15 years. Currently he is leading Center of Excellence Pfizer Essential Health Japan and focusing on resourcing optimization of the Essential Health business includes the digital transformation of a commercial model that can respond to local business needs with global/regional alignment fulfill diverse business needs with flexibility and streamlined decision making for innovate go to market model.
Hiroshi Kowaki, Alnylam
Hiroshi Kowaki, Country Commercial Lead, Alnylam
Yuichi Kubo, Daiichi
Yuichi Kubo, Board of Director, Head of New Product Development, Daiichi
Susumu Misumori, Shionogi
Susumu Misumori, Vice President, Sales Planning Department, Shionogi
Nobuo Murakami, Daiichi Sankyo
Nobuo Murakami, Senior Director, Daiichi Sankyo
Noriko Nishi, Shionogi & Co.
Noriko Nishi, Vice President and Head of Global New Product Planning, Global Development, Shionogi & Co., Ltd.
Satoru Noguchi, Celgene
Satoru Noguchi, President, Celgene
Rafaat Rahmani, Lifescience Dynamics
Rafaat Rahmani, President, Lifescience Dynamics
Rafaat founded Lifescience Dynamics in the summer of 2004. He had a vision of what would make an effective global decision support service, dedicated exclusively to pharmaceutical and biotechnology industries. It would have to be the best in class market research, competitive intelligence and market access, combined with first-rate people and a business model that met their clients’ global insight and foresight requirements. He wanted to deliver a unique service model that hadn’t been available to the market previously, giving pharmaceutical companies a new and interesting way to manage their market, competitors and payer requirements.
Lifescience Dynamics is headquartered in London with offices in New York. They are privileged to boast an extraordinary worldwide customer base, with teams across the globe supporting firms of all sizes, from top 20 pharmaceutical companies through to smaller niche pharma and biotech firms. Lifescience Dynamics has undertaken research across 86 countries.
Prior to founding Lifescience Dynamics, Rafaat was Vice President of a London-based consulting practice where he was responsible for numerous international projects for top 10 pharmaceutical companies, focusing on all aspects of the clinical development and commercialisation environments at US, European and global levels.
Rafaat holds a Bachelor Business Administration from University of Huston, Texas, USA and an MBA from the Manchester Business School, Manchester, UK.
Ajai Sulekh, Biogen
Ajai Sulekh, Managing Director, Biogen
Ajai Sulekh serves as Managing Director at Biogen Japan. He is responsible for overseeing the entire operations of the Japanese affiliate, including two business units, Multiple Sclerosis & Spinal Muscular Atrophy, and the management of functions essential to commercial operations including marketing, salesforce productivity such as data analytics, sales training, and sales incentive administration. In addition, he leads Biogen Japan’s new product planning, wholesaler management and partnership management function.
Prior to joining Biogen, he held roles of increasing responsibility in sales, product & brand management, marketing and then strategic planning and business development for a variety of pharmaceutical companies, including Eli Lilly, Abbott, MSD and most recently, Merck & Co. He draws broad perspectives in commercial area by not only spending time at the affiliates but also working at Global Head Office. Ajai also has strategy consulting experience with Accenture. He holds a Master of Science degree from Tokyo University in Japan and MBA from IMD Lausanne in Switzerland.
Hiroaki Suzuki, Vetter Pharma
Hiroaki Suzuki, Country Manager, Vetter Pharma
Hiroaki has been with Vetter Pharma International Japan, a global leading German CDMO, for 3-plus years as Country Manager. Prior to that, Hiroaki has gained extensive knowledge on Market Research / Commercial Excellence through his work at ZS Associates and Actelion Pharmaceuticals Japan, now a J&J company.
Hiroaki holds bachelor’s degree in Chemical Engineering from Waseda University and holds MBA from McDonough School of Business at Georgetown University. Hiroaki has once been as guest scientist at National Council Canada for one-year earlier in his professional career.
Atsuhito Tomotsugu, Takeda
Atsuhito Tomotsugu, Director, Takeda
Hanson Zheng, Bristol Myers Squibb
Hanson Zheng, Director, Customer Insights & Analytics, Bristol Myers Squibb